{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036161","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.667806+00:00","generated_at":"2026-05-31T04:53:59.296031+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Regen Biopharma issues $250K promissory note to Coventry; $25K OID, convertible on default","bullets":["Principal amount $250K; original issue discount $25K, net proceeds $200K.","10% annual interest; ten monthly payments of $27,500 starting Nov 4, 2024, due Sept 4, 2025.","Upon event of default, note converts to common stock at 90% of lowest 20-day trading price before conversion.","Company issued 500K commitment shares; 350K to be returned to treasury if no default occurs.","$152K of proceeds used to repay existing principal and interest to Coventry from a prior note."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036161","json":"https://secwatch.observer/filing/0001493152-24-036161.json","markdown":"https://secwatch.observer/filing/0001493152-24-036161.md","text":"https://secwatch.observer/filing/0001493152-24-036161.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000149315224036161/0001493152-24-036161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000149315224036161/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:53:59.296031+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}